| Literature DB >> 35464009 |
Tinu M Samuel1, Frank Thielecke2, Luca Lavalle1, Cheng Chen1, Paul Fogel3, Francesca Giuffrida1, Stephane Dubascoux1, Cecilia Martínez-Costa4, Kirsti Haaland5, Giovanna Marchini6, Massimo Agosti7, Thameur Rakza8, Maria Jose Costeira9, Jean-Charles Picaud10, Claude Billeaud11, Sagar K Thakkar12.
Abstract
Background: The effect of the mode of neonatal delivery (cesarean or vaginal) on the nutrient composition of human milk (HM) has rarely been studied. Given the increasing prevalence of cesarean section (C-section) globally, understanding the impact of C-section vs. vaginal delivery on the nutrient composition of HM is fundamental when HM is the preferred source of infant food during the first 4 postnatal months. Objective: This study aimed to evaluate the association between mode of delivery and nutrient composition of HM in the first 4 months of life. Design: Milk samples were obtained from 317 healthy lactating mothers as part of an exploratory analyses within a multicenter European longitudinal cohort (ATLAS cohort) to study the HM composition, and its potential association with the mode of delivery. We employed traditional mixed models to study individual nutrient associations adjusted for mother's country, infant birth weight, parity, and gestational age, and complemented it, for the first time, with a multidimensional data analyses approach (non-negative tensor factorization, NTF) to examine holistically how patterns of multiple nutrients and changes over time are associated with the delivery mode.Entities:
Keywords: C-section = caesarean section; human milk; inflammation; longitudinal cohort; mode of delivery; vaginal birth
Year: 2022 PMID: 35464009 PMCID: PMC9033294 DOI: 10.3389/fnut.2022.834394
Source DB: PubMed Journal: Front Nutr ISSN: 2296-861X
Participant inclusion and exclusion criteria.
|
|
| Between 18 and 40 of age at the time of enrollment |
| BMI before pregnancy between 19 and 29, inclusive |
| Having decided to exclusively breast-feed from birth up to 4 months of age |
| Signed the informed consent form |
|
|
| Participation in another clinical study during the 4 weeks prior to the beginning of this study |
| Medical condition which prevented breast-feeding or collection of human milk samples or for which breast-feeding is not indicated |
| Diseases/medical conditions such as diabetes, heart problems, abnormal conditions of pregnancy (e.g., hypertension), anorexia, bulimia, and celiac disease |
| Medications indicated for the treatment of any metabolic or cardiovascular disease |
| Non-compliance with the study procedures |
| Mothers given birth to twins |
FIGURE 1Development of n-6/n-3 ratio, PUFA%, and the ARA/DHA ratio across visits and per C-section density grouping. N 0 to N 109 = the group with a high-density C-section group. N 110 to N 244 = the group with a low-density C-Section group.
FIGURE 2Development of FSLT2, Iodine, MUFA%, and 20:1n-9 ratio across visits and per C-section density grouping. N 0 to N 115 = the group with a high-density C-section group. N 116 to N 244 = the group with a low-density C-Section group.
FIGURE 3Flow chart on the cohort analysis.
Maternal and infant characteristics.
| C-section (Tot. = 80) | Vaginal (Tot. = 237) | |||||||
| Visits |
|
| [Q1,Q3] or % |
|
| [Q1,Q3] or% | ||
|
| ||||||||
| 80 | 32 | [28, 34] | 237 | 31 | [28, 34] | 0.45 | ||
| Maternal pre-pregnancy BMI | 80 | 22.2 | [22.6, 25.2] | 237 | 22.1 | [22.6, 25.2] | 0.59 | |
|
| ||||||||
| Child’s birth | 78 | 28.1 | [24.5, 31.1] | 221 | 27.4 | [25.0, 29.7] | 0.43 | |
| 0–3 days | 79 | 26.6 | [23.8, 29.9] | 227 | 25.5 | [23.6, 28.3] | 0.1 | |
| 17 ± 3 days | 73 | 25.4 | [22.4, 27.3] | 218 | 24.4 | [22.4, 26.7] | 0.22 | |
| 30 ± 3 days | 66 | 25.0 | [21.9, 27.2] | 200 | 24.1 | [22.1, 26.4] | 0.33 | |
| 60 ± 5 days | 60 | 24.9 | [22.1, 26.9] | 186 | 23.9 | [21.7, 26.2] | 0.25 | |
| 90 ± 5 days | 57 | 24.5 | [22.2, 26.9] | 176 | 23.7 | [21.5, 26.0] | 0.11 | |
| 120 ± 5 days | 56 | 24.5 | [21.9, 27.2] | 167 | 23.3 | [21.3, 25.5] | 0.1 | |
|
| ||||||||
| Spain | 3 | 3.80% | 10 | 4.20% | < 0.01 | |||
| France | 10 | 12.50% | 78 | 32.90% | ||||
| Italy | 1 | 1.20% | 19 | 8% | ||||
| Norway | 0 | 0% | 9 | 3.80% | ||||
| Portugal | 28 | 35% | 72 | 30.40% | ||||
| Romania | 34 | 42.50% | 10 | 4.20% | ||||
| Sweden | 4 | 5% | 39 | 16.50% | ||||
|
| ||||||||
| Primiparous | 68 | 85% | 171 | 72.20% | 0.03 | |||
| Multiparous | 12 | 15% | 66 | 27.80% | ||||
|
| ||||||||
| 80 | 39 | [38.0, 39.0] | 237 | 40 | [39, 40] | < 0.01 | ||
|
| ||||||||
| Child’s birth | 79 | 34.0 | [33.0, 35.0] | 237 | 34.8 | [34.0, 35.5] | < 0.01 | |
| 0–3 days | 78 | 34.0 | [33.0, 35.0] | 235 | 34.6 | [34.0, 35.5] | 0.01 | |
| 17 ± 3 days | 73 | 35.4 | [34.5, 36.6] | 219 | 36.3 | [35.5, 37.0] | < 0.01 | |
| 30 ± 3 days | 66 | 37.0 | [36.0, 38.0] | 201 | 37.5 | [36.5, 38.5] | < 0.01 | |
| 60 ± 5 days | 60 | 38.9 | [38.0, 39.5] | 186 | 39.2 | [38.3, 40.0] | 0.02 | |
| 90 ± 5 days | 57 | 40.5 | [40.0, 41.0] | 176 | 40.7 | [39.5, 41.5] | 0.49 | |
| 120 ± 5 days | 56 | 41.5 | [41.0, 42.2] | 167 | 41.5 | [41.0, 42.5] | 0.61 | |
|
| ||||||||
| Child’s birth | 80 | 0.13 | [−0.73, 0.74] | 236 | 0.33 | [−0.35, 0.99] | 0.24 | |
| 0−3 days | 79 | –0.08 | [−0.90, 0.40] | 234 | 0.09 | [−0.53, 0.77] | 0.14 | |
| 17 ± 3 days | 73 | –0.49 | [−1.14, 0.11] | 219 | 0.00 | [−0.67, 0.71] | < 0.01 | |
| 30 ± 3 days | 66 | –0.47 | [−1.19, 0.12] | 200 | 0.04 | [−0.81, 0.71] | < 0.01 | |
| 60 ± 5 days | 59 | –0.50 | [−1.12, 0.20] | 186 | –0.02 | [−0.74, 0.66] | < 0.01 | |
| 90 ± 5 days | 56 | –0.24 | [−0.93, 0.26] | 176 | –0.05 | [−0.67, 0.67] | 0.04 | |
| 120 ± 5 days | 56 | −0−−0.1 | [−1.05, 0.49] | 168 | –0.06 | [−0.68, 0.66] | 0.27 | |
|
| ||||||||
| Child’s birth | 80 | –0.22 | [−0.88, 0.41] | 237 | 0.19 | [−0.39, 0.87] | < 0.01 | |
| 0−3 days | 79 | –0.55 | [−1.18, 0.04] | 235 | –0.13 | [−0.78, 0.48] | < 0.01 | |
| 17 ± 3 days | 73 | –0.66 | [−1.24, 0.03] | 219 | 0.03 | [−0.62, 0.53] | < 0.01 | |
| 30 ± 3 days | 66 | –0.61 | [−1.02, 0.05] | 201 | 0.07 | [−0.65, 0.59] | < 0.01 | |
| 60 ± 5 days | 60 | –0.61 | [−1.15, -0.02] | 186 | –0.11 | [−0.77, 0.47] | < 0.01 | |
| 90 ± 5 days | 57 | –0.52 | [−1.11, 0.35] | 176 | –0.15 | [−0.79, 0.45] | 0.06 | |
| 120 ± 5 days | 56 | –0.52 | [−1.04, 0.30] | 168 | –0.17 | [−0.86, 0.42] | 0.13 | |
|
| ||||||||
| Male | 44 | 55% | 127 | 53.60% | 0.93 | |||
| Female | 36 | 45% | 110 | 46.40% | ||||
Sample size, median, 1st quartile (Q1 = 25th percentile), 3rd quartile (Q3 = 75th percentile), and p-value (Mann- Whitney U test) for continuous characteristics. For categorical characteristics, count, percentage, and p-value (Pearson’s chi-squared test).
FIGURE 4Comparison of fatty acid content between vaginal delivery and C-section per visit (Mann-Whitney test U test unadjusted for multiple comparisons).
FIGURE 5Comparison of human milk oligosaccharides between vaginal delivery and C-section per visit (Mann-Whitney U test unadjusted for multiple comparisons).
FIGURE 6Comparison of components of human milk other than fatty acids between vaginal delivery and C-section per visit (Mann-Whitney U test unadjusted for multiple comparisons).